December 2002
Volume 43, Issue 13
ARVO Annual Meeting Abstract  |   December 2002
Injection of 5-fluorouracil (5-FU) at the Trabeculectomy Site Has Minor Effects in the Anterior Chamber
Author Affiliations & Notes
  • ER Crouch
    TR Lee Center for Ocular Pharmacology Eastern Virginia Med School Norfolk VA
  • PD Samuel
    Norfolk VA
  • PB William
    Norfolk VA
  • SS Samudre
    Norfolk VA
  • PV Mitrev
    Norfolk VA
  • FA Lattanzio
    Norfolk VA
  • Footnotes
    Commercial Relationships   E.R. Crouch, None; P.D. Samuel , None; P.B. William , None; S.S. Samudre , None; P.V. Mitrev , None; F.A. Lattanzio , None. Grant Identification: Supported in part: Am. Health Assistance Fdn
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 4102. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      ER Crouch, PD Samuel, PB William, SS Samudre, PV Mitrev, FA Lattanzio; Injection of 5-fluorouracil (5-FU) at the Trabeculectomy Site Has Minor Effects in the Anterior Chamber . Invest. Ophthalmol. Vis. Sci. 2002;43(13):4102.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: To prevent fibrosis of the filtering bleb, after trabeculectomy 5-FU may be injected at the bleb site. 5-FU is extremely caustic and topical administration can cause corrosive damage. This study ascertained whether repeated injection of 5-FU into the bleb has toxic effects on intraocular structures. Methods: After unilateral trabeculectomy in anesthetized New Zealand rabbits, 5-FU (5.0 mg) was injected at the trabeculectomy site weekly for 3 wk. Slit lamp and confocal microscopy, for in vivo evaluation, and IOP were performed weekly. After sacrifice, aqueous humor (AH) was drawn and eyes excised for examination of the anterior chamber structures by scanning electron microscopy (SEM) and light microscopy. Results: 5-FU injection had no effect on IOP beyond that of trabeculectomy. Bleb height remained constant, thickness increased and vascularity decreased without necrosis or inflammation of surrounding tissue. Protein in AH increased to 19.784.45 ug/ml after trabeculectomy but only to 0.890.62 ug/ml after 5-FU injection. In vivo confocal microscopy revealed consistent epithelial and endothelial cell number and size similar to control eyes. Similarly, analysis by SEM of corneal endothelium showed a minor shift toward smaller cells, based on area in the treatment group compared to controls. SEM of corneal epithelium revealed a similar shift toward smaller cells but a wider range of cell size. By light microscopy, no inflammation was observed in the bleb or surrounding tissues. There were no differences in cornea, Schlemm«s canal, ciliary body, iris pigmented epithelium and stroma, secretory epithelium or lens between the treated and control eyes. Conclusions: Injection of 5-FU into the bleb did not provoke an intraocular inflammatory response and was not toxic to extraocular structures. Repeated administration did not cause cumulative toxic effects to intraocular structures including no significant changes to corneal epithelium and endothelium. In vivo measurements of corneal epithelium and endothelium by confocal microscopy were confirmed by SEM. Therefore, multiple injections of 5-FU into the filtering bleb pose minimal risk to intraocular structures.

Keywords: 390 drug toxicity/drug effects • 471 microscopy: confocal/tunneling • 317 anterior chamber 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.